Background: Extraintestinal manifestations (EIMs) in pediatric patients with inflammatory bowel disease (IBD) are poorly characterized. We examined the prevalence of EIMs at diagnosis, subsequent incidence, and risk factors for EIMs. ## Methods: Data for 1649 patients from the PediIBD Consortium
The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease
β Scribed by Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 215 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The inflammatory bowel diseases (IBD), notably Crohn's disease (CD) and ulcerative colitis (UC), are systemic inflammatory diseases primarily involving the gastrointestinal tract. Twenty percent to 40% of patients with IBD develop extraintestinal inflammation and symptoms, known as extraintestinal m
## Background: Ophthalmologic diseases in patients with inflammatory bowel disease (ibd) have been reported with varying frequency, mostly from tertiary referral centers. the aim was to describe the spectrum of ophthalmologic conditions in patients with ibd in a community setting and to compare it